ROBERT WOOD JOHNSON FOUNDATION - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 114 filers reported holding ACCELERON PHARMA INC in Q4 2014. The put-call ratio across all filers is 0.52 and the average weighting 1.6%.

Quarter-by-quarter ownership
ROBERT WOOD JOHNSON FOUNDATION ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q4 2014$52,0001,3430.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2014
NameSharesValueWeighting ↓
Artal Group S.A. 1,400,000$133,378,0003.73%
Foresite Capital Management III, LLC 42,030$4,004,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 257,249$24,508,0002.23%
Cormorant Asset Management, LP 600,000$57,162,0002.18%
Avoro Capital Advisors LLC 1,040,000$99,081,0001.96%
QVT Financial LP 101,396$9,660,0001.64%
FARALLON CAPITAL MANAGEMENT LLC 2,100,000$200,067,0001.60%
Rhenman & Partners Asset Management AB 155,000$14,767,0001.60%
Parkman Healthcare Partners LLC 57,500$5,478,0001.54%
Ikarian Capital, LLC 187,700$17,882,0001.42%
View complete list of ACCELERON PHARMA INC shareholders